Showing 17–32 of 39 results
-
Exocrine Pancreatic Insufficiency (EPI)
Be a part of our research dedicated to finding effective solutions for managing Exocrine Pancreatic Insufficiency. We aim to improve treatment protocols and outcomes for EPI patients.
Read more
Criteria & Qualifications: • Diagnosed with Exocrine Pancreatic Insufficiency. • Aged 18 years or older.
• Willing to follow the study protocol and attend all required appointments.
Compensation: Contact us for more information -
Hypertriglyceridemia Study
Support our research into new Hypertriglyceridemia treatments by getting involved in our study. Your contribution can lead to better management of triglyceride levels.
Read more
Criteria & Qualifications: • Diagnosed with severe Hypertriglyceridemia (SHTG) with high triglyceride levels confirmed by medical records.
• Must be 18 or older with the ability to consent.
• Currently taking medications to lower triglycerides.
Compensation: Contact us for more information -
Hypertriglyceridemia Trial
Be part of our research to develop better Hypertriglyceridemia treatments. Your involvement can help improve triglyceride level management.
Read more
Criteria & Qualifications: • Diagnosed with Hypertriglyceridemia (HTG) and triglyceride levels between 150–499 mg/dL.
• 18 years or older and able to provide consent.
• Willing to follow a low-fat diet during the study.
Compensation: Contact us for more information -
Inflammatory Bowel Disease
Join us in advancing the understanding of treatments for IBD. Help researchers evaluate the safety and effectiveness of approved therapies for Crohn’s disease and Ulcerative Colitis.
Read more
Criteria & Qualifications: • 18 years or older.
• Diagnosed with Crohn’s disease or Ulcerative Colitis.
• Currently using or recently started an approved treatment for IBD.
Compensation: Contact us for more information -
NASH
Participating in this clinical trial can help improve treatments for a liver condition called MASH/NASH, which causes liver damage. The study is testing a new medicine to see if it can help improve liver health for people with moderate to advanced liver fibrosis. Criteria & Qualifications: • Must be 18 years or older. • Diagnosed with MASH/NASH and have moderate to advanced liver fibrosis. • Cannot join if you have other liver diseases or a history of chronic alcohol use. Compensation: Contact us for more information
Read more -
NASH/MASH
Help us improve treatment options for people with NASH and related health conditions. This clinical trial is studying a once-monthly therapy to reduce liver fat and improve metabolic health in diverse populations.
Read more
Criteria & Qualifications: • Adults diagnosed with NASH.
• Includes people with pre-diabetes or type 2 diabetes.
• Open to individuals seeking better liver and metabolic health management.
Compensation: Contact us for more information -
NASH/MASH Study
Nonalcoholic fatty liver disease (NAFLD) is a condition where fat accumulates in the liver. NASH, the more severe form, causes swelling and damage to the liver. Currently, there is no existing treatment for NASH/MASH.
Read more
Criteria & Qualifications: • Is at least 18 years of age or older.
• Inflammation and liver damage, also known as Nonalcoholic steatohepatitis (NASH).
• Must be weight stable for 6 months.
Compensation: Up to $3,000. -
NASH/MASH Trial
NASH/MASH is a liver disease with inflammation and damage from fat buildup. If you have NASH/MASH, consider participating in our study to help find new treatments.
Read more
Criteria & Qualifications: • Must be 18 years or older.
• Diagnosed with Ulcerative Colitis.
• Is willing to provide medical records.
Compensation: Contact us for more information. -
Obesity
We are conducting a clinical study to evaluate the safety and tolerability of new health interventions. Your participation will help researchers gain valuable insights into improving treatments and overall well-being.
Read more
Criteria & Qualifications: • Ages 18 to 65 years old.
• BMI between 30 and 40 kg/m².
• Non-pregnant females only.
Compensation: Contact us for more information -
Obesity Trial
Join a clinical trial that aims to improve health outcomes for people living with obesity or being overweight. This study is testing a new medication to see how it can reduce health risks and improve the overall quality of life for individuals managing obesity. Criteria & Qualifications: • Must be 18 years or older. • Living with obesity or overweight. • Not currently taking medications for weight loss. Compensation: Contact us for more information
Read more -
Pediatric Obesity
This clinical trial is evaluating a new medication to improve health outcomes for adolescents living with obesity or overweight with weight-related health conditions. The goal is to assess how this treatment can reduce health risks and enhance quality of life.
Read more
Criteria & Qualifications: • Must be an adolescent.
• Living with obesity or overweight with related comorbidities.
• Not currently taking medications for weight management.
Compensation: Contact us for more information -
Pediatric Respiratory Syncytial Virus (RSV)
We’re conducting a study to explore a new option for children with respiratory syncytial virus (RSV). This research aims to better understand how it can support recovery and overall health. Criteria & Qualifications: • Must be under 18 years old. • Diagnosed with RSV. • May have health factors like certain medical conditions. Compensation: Contact us for more information
Read more -
Pneumococcal Vaccine
We’re conducting a study to evaluate vaccines for infants to enhance their protection against common illnesses. Your baby's participation could contribute to advancing pediatric care while receiving routine vaccinations.
Read more
Criteria & Qualifications: • Infants aged 2 to 3 months.
• Healthy and medically stable.
• Born full-term or preterm but meeting weight requirements.
Compensation: Contact us for more information -
Pneumococcal Vaccine Study
Support groundbreaking research by participating in our Pneumococcal Vaccine Study. Your involvement could help improve vaccine protection for children everywhere. Criteria & Qualifications: • Your child is eligible if they meet the study's age requirements. • Able to commit to 7–8 study visits over a period of 16–19 months. • Parent or guardian must be able to attend all 7–8 study visits over 16–19 months. Compensation: Contact us for more information.
Read more -
Respiratory Syncytial Virus (RSV)
We’re conducting a study to evaluate a new treatment for adults with acute respiratory syncytial virus (RSV) infection. The goal is to understand how this treatment may help reduce symptoms faster and improve health outcomes. Criteria & Qualifications: • Must be 18 years or older. • Diagnosed with acute RSV infection. • Exhibits risk factors such as age 60+, chronic lung diseases, or cardiovascular conditions. Compensation: Contact us for more information
Read more -
Respiratory Syncytial Virus (RSV) Study
Participate in an RSV vaccine study to combat lung infections. Help us understand vaccine effects in diverse health conditions. Eligibility criteria apply. Criteria & Qualifications: • Must be 18 years or older and diagnosed with RSV within the last 5 days. • Experiencing new or worsening symptoms like cough or shortness of breath within 5 days before randomization. • Either aged 65+, or have chronic lung disease, heart failure, or an immunosuppressive condition. Compensation: Contact us for more information
Read more